38,000 options granted to iBio (IBIO) director Alexandra Kropotova vest monthly over 12 months.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
iBio, Inc. director Alexandra Kropotova was granted 38,000 stock options on October 14, 2026, with an exercise price of $0.7800 per share. These options will vest pro rata in monthly installments over twelve months, beginning one month after the grant date, provided she continues her service. The options are set to expire on October 13, 2036.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.